School of Life Science and Technology, University of Electronic Science and Technology of China
Chengdu, Sichuan, China
NCT Number: NCT04105140
To investigate whether intranasal oxytocin (24 IU) treatment can influence prosocial learning behavior in males.
Looking for future studies?
Notify Me18 year–30 year
Male
Interventional
Not applicable
Chengdu, Sichuan, China
In a double-blind, within-subject, placebo controlled design, investigators plan to investigate the effect of oxytocin treatment on prosocial learning. Before the self-administration, participants need to finish several questionnaires including IRI, AAS, BASBIS, SPSRQ, SES, PTM, STAI, BDI, ASQ and PNAS. They would finish the PANAS again before the scanning.
Participants are informed that they perform the reward learning task either for themselves, another (unknown) person or no one (control). In the probabilistc reward learning task, associations with two stimuli with different reward probabilities are learned via monetary feedback (reward ¥1 or no reward ¥0). After the experiment, participants need to finish the PANAS.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
intranasal administration of oxytocin (24 IU)
intranasal administration of placebo (24 IU)
Time frame: 1 hour
fMRI BOLD indices of neural processing learning related brain regions will be compared between the treatment administrations.
Time frame: 1 hour
Learning performance will be compared between the treatment administrations by calculating the accuracy of learning.
University of Electronic Science and Technology of China
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01866852
Healthy
Bethesda, Maryland, United States
View Trial DetailsNCT05531396
Elderly, Healthy
Taipei, Taiwan
View Trial DetailsNCT07629414
Healthy, Heat Stress Disorders
Shreveport, Louisiana, United States
View Trial DetailsNCT07531628
Healthy
Hangzhou, China
View Trial Details